NCS-382 |
Catalog No.GC12169 |
γ-Hydroxybutyric acid antagonist
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 520505-01-5
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 520505-01-5 | SDF | |
Chemical Name | (S,E)-2-(5-hydroxy-8,9-dihydro-5H-benzo[7]annulen-6(7H)-ylidene)acetic acid | ||
Canonical SMILES | O[C@@H]1C2=CC=CC=C2CCC/C1=C\C(O)=O | ||
Formula | C13H14O3 | M.Wt | 218.25 |
Solubility | <21.83mg/ml in DMSO | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.5819 mL | 22.9095 mL | 45.819 mL |
5 mM | 0.9164 mL | 4.5819 mL | 9.1638 mL |
10 mM | 0.4582 mL | 2.291 mL | 4.5819 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC11341 LY 2365109 hydrochloride
- GC60970 KY19382
- GC42272 3-formyl Rifamycin
- GC30763 Benzenebutyric acid (4-Phenylbutyric acid)
- GC35573 c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 acetate
- GC35868 DIPQUO
- GC34980 (E)-Ferulic acid
- GC38074 PDP-Pfp
- GC19372 Velpatasvir
- GC15127 Locustatachykinin I
- GC19485 DC661
- GC50430 Squarunkin A hydrochloride
- GC14253 Cefapirin
- GC13785 BRL 37344, sodium salt
- GC33315 AGN 194078
- GC35270 Agomelatine L(+)-Tartaric acid
- GC36747 Nitroaspirin
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *